A Collaborative Theory-based Intervention to Promote Physical Activity Among Sedentary Parents and Their Children
Launched by UNIVERSITY OF JYVASKYLA · Oct 3, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program designed to help parents and their children become more physically active. It focuses on families who currently do not meet recommended activity levels—parents should aim for at least 150 minutes of moderate exercise each week, while children should get 60 minutes of active play every day. The study is looking for parents who are not reaching these goals and have children aged 8 to 12 years old.
Participants in the trial will be divided into two groups: one group will receive the new program, which includes online meetings and support materials, while the other group will simply provide measurements and wait for the program to be offered later. The program will teach families about motivation and goal-setting to help them increase their activity levels together. Throughout the trial, researchers will track how much physical activity both parents and children are doing, as well as their attitudes about exercise. This study aims to find effective ways to encourage families to be more active, which can improve their overall health and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent does not undertake at least 150 minutes of moderate-intensity (or 75 minutes of vigorous-intensity) physical activity each week.
- • Child does not undertake at least 60 minutes of moderate-intensity or vigorous-intensity physical activity each day.
- • Child is aged between 8 and 12 years old
- Exclusion Criteria:
- • Parent reports that either they or their child is currently meeting physical activity guidelines at screening.
- • Parent states that they or their child has some physical condition that prohibits them from safely participating in physical activity.
About University Of Jyvaskyla
The University of Jyväskylä is a leading research institution in Finland, renowned for its commitment to advancing knowledge through innovative scientific inquiry and interdisciplinary collaboration. With a strong emphasis on health sciences, the university conducts cutting-edge clinical trials aimed at improving patient outcomes and enhancing public health. Its research initiatives are supported by state-of-the-art facilities and a team of experienced professionals dedicated to ethical research practices and the translation of scientific findings into real-world applications. The university fosters an environment of academic excellence and is dedicated to contributing to the global body of medical knowledge through rigorous research and development.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jyväskylä, Keski Suomi, Finland
Patients applied
Trial Officials
Martin Hagger
Principal Investigator
University of Jyvaskyla
Keegan Knittle
Principal Investigator
University of Jyvaskyla
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported